TrialBlood2015

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Heinz Gisslinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.